We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Incidence of Cervical and Vaginal Dysplasia After Exposure to DES-Reply

Stanley J. Robboy, MD; W. Dwayne Lawrence, MD; Kenneth L. Noller, MD; Peter O'Brien, PhD; Eric Bergstrahl; Susan McGorray; Barbara C. Tilley, PhD; Raymond H. Kaufman, MD
JAMA. 1986;255(1):37. doi:10.1001/jama.1986.03370010038014.
Text Size: A A A
Published online


In Reply.—  Dr Richart asserts that advances in our knowledge about the morphological appearances of HPV could have led to bias in the National Collaborative Diethylstilbestrol Adenosis Project study, in which tissue slides have been analyzed since 1976.1 Although some bias is possible, we believe it to be minimal since the slides disclosing dysplasia were reviewed by all pathologists and cytologists, and many slides were rereviewed periodically over a period of years as part of quality-control procedures.A major problem facing all pathologists and cytologists today is in fact the diagnostic criteria distinguishing HPV lesions from dysplasia and carcinoma in situ (collectively, Richart's CIN). Do lesions exhibiting both koilocytosis and marked nuclear atypia represent one disease state or both simultaneously? We have demonstrated that such lesions may have HPV demonstrable by immunoperoxidase stains while also demonstrating aneuploidy by microspectrophotometric analysis of Feulgen-stained slides.2 We believe that many lesions


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.